Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Calancardin B may help reduce inflammation in immune cells.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Kerion cases had longer disease duration but responded well to antifungal treatments.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Cancer prevention has advanced significantly, with some strategies proving successful.

Baricitinib is more effective than methotrexate for severe alopecia areata.

The treatment was ineffective in humans.

Alefacept does not effectively treat severe alopecia areata.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Blocking mTORC1 reduces skin tumor growth in mice.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

SM04755 may be an effective topical treatment for psoriasis.